Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
The Oncologist|September 30, 2018
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent GlioblastomaAlba A Brandes, Miguel Gil-Gil, Frank Saran, et al.Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.Neuro-Oncology|May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoterMichael Lim, Michael Weller, Ahmed Idbaih, et al.The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.Cell Reports|July 28, 2023
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomasFrancesca De Bacco, Francesca Orzan, Giovanni Crisafulli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type GliomaAnna Luisa Di Stefano, Alessandra Fucci, Veronique Frattini, et al.Nature Genetics|August 7, 2013
The integrated landscape of driver genomic alterations in glioblastomaVeronique Frattini, Vladimir Trifonov, Joseph Minhow Chan, et al.The International Journal of Biological Markers|September 30, 2009
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysisAngelo Paradiso, Anita Mangia, Claudio Orlando, et al.Cell|November 19, 2016
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive GrowthBaoli Hu, Qianghu Wang, Y Alan Wang, et al.Nature Medicine|June 1, 2026
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trialBernhard Gentner, Marica Eoli, Francesca Farina, et al.Pageof 13